Login / Signup

Non-invasive brain stimulation as add-on therapy for subacute post-stroke aphasia: a randomized trial (NORTHSTAR).

Anna ZumbansenSandra E BlackJoyce L ChenDylan J EdwardsAlexander HartmannWolf-Dieter HeissSylvain LanthierPaul LesperanceGeorge MochizukiCaroline PaquetteElizabeth A RochonIlona Rubi-FessenJennie VallesHeike KneifelSusan Wortman-JuttAlexander Thielnull null
Published in: European stroke journal (2020)
Naming was significantly improved by rTMS (median = 1.91/interquartile range = 0.77/p = .01) at 30 days versus ctDCS (median = 1.11/interquartile range = 1.51) and sham stimulation (median = 1.02/interquartile range = 1.71). All other primary results were non-significant. The rTMS effect was driven by the patient subgroup with intact Broca's area where NIBS tended to improve UnAS (median = 33.2%/interquartile range = 46.7%/p = .062) versus sham stimulation (median = 12.5%/interquartile range = 7.9%) at day 30. Conversely, in patients with infarcted Broca's area, UnAS tended to improve more with sham stimulation (median = 75.0%/interquartile range = 86.9%/p = .053) versus NIBS (median = 12.7%/interquartile range = 31.7).Conclusion: We found a delayed positive effect of low-frequency rTMS targeting the right pars triangularis on the recovery of naming performance in subacute post-stroke aphasia. This intervention may be beneficial only in patients with morphologically intact Broca's area.
Keyphrases
  • transcranial magnetic stimulation
  • randomized controlled trial
  • clinical trial
  • double blind
  • multiple sclerosis
  • high frequency
  • case report
  • cancer therapy
  • open label
  • cerebral ischemia
  • functional connectivity